Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

10x Genomics, Inc. TXG

Full chart Compare
Set alert

Price alert · TXG

All alert types
67.52 USD +2.23 (+3.42%)

At closeNov 4, 2026, 5:04 PM EST

67.52 0.00 0.00%

After hours · Nov 4, 5:04 PM ET

62.88 Day range 68.32
12.80 52-week range 102.81
YTD
+313.98%
1 year
+405.39%

Financial health

Altman Z-Score

22.17 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 1

Valuation

P/E -46.6×
FY 2017: -32.6×FY 2018: -6.3×FY 2019: -95.3×FY 2020: -26.4×FY 2021: -281×FY 2022: -25.0×FY 2023: -25.7×FY 2024: -9.4×FY 2025: -46.6×
FY 2017 5y median -25.7× FY 2025
P/S 3.2×
FY 2017: 8.6×FY 2018: 4.8×FY 2019: 12.1×FY 2020: 47.9×FY 2021: 33.5×FY 2022: 8.0×FY 2023: 10.6×FY 2024: 2.8×FY 2025: 3.2×
FY 2017 5y median 8.0× FY 2025
P/B 2.6×
FY 2017: -5.4×FY 2018: -3.2×FY 2019: 7.1×FY 2020: 19.4×FY 2021: 20.1×FY 2022: 5.1×FY 2023: 8.8×FY 2024: 2.4×FY 2025: 2.6×
FY 2017 5y median 5.1× FY 2025
P/FCF 15.6×
FY 2017: -42.3×FY 2018: -8.5×FY 2019: -366×FY 2020: -55.9×FY 2021: -134×FY 2022: -25.1×FY 2023: -101×FY 2024: -302×FY 2025: 15.6×
FY 2017 5y median -101× FY 2025
EV/EBITDA 440×
FY 2017: -42.1×FY 2018: -6.3×FY 2019: -124×FY 2020: -26.7×FY 2021: -648×FY 2022: -31.3×FY 2023: -30.7×FY 2024: -11.0×FY 2025: 440×
FY 2017 5y median -30.7× FY 2025
EV/Sales 2.7×
FY 2017: 8.1×FY 2018: 4.6×FY 2019: 10.5×FY 2020: 45.9×FY 2021: 32.5×FY 2022: 7.8×FY 2023: 10.2×FY 2024: 2.4×FY 2025: 2.7×
FY 2017 5y median 7.8× FY 2025
FCF Yield 6.4%
FY 2017: -2.4%FY 2018: -11.8%FY 2019: -0.3%FY 2020: -1.8%FY 2021: -0.7%FY 2022: -4.0%FY 2023: -1.0%FY 2024: -0.3%FY 2025: 6.4%
FY 2017 5y median -0.7% FY 2025

Profitability

Gross Margin 69.1%
FY 2017: 85.1%FY 2018: 80.4%FY 2019: 75.2%FY 2020: 80.4%FY 2021: 84.9%FY 2022: 76.7%FY 2023: 66.2%FY 2024: 67.9%FY 2025: 69.1%
FY 2017 5y median 69.1% FY 2025
Operating Margin -17.2%
FY 2017: -25.8%FY 2018: -75.7%FY 2019: -11.8%FY 2020: -28.6%FY 2021: -10.8%FY 2022: -32.5%FY 2023: -42.9%FY 2024: -31.9%FY 2025: -17.2%
FY 2017 5y median -31.9% FY 2025
Net Margin -6.8%
FY 2017: -26.4%FY 2018: -76.9%FY 2019: -12.7%FY 2020: -181.6%FY 2021: -11.9%FY 2022: -32.1%FY 2023: -41.2%FY 2024: -29.9%FY 2025: -6.8%
FY 2017 5y median -29.9% FY 2025
ROE -5.5%
FY 2017: 16.7%FY 2018: 51.1%FY 2019: -7.4%FY 2020: -73.4%FY 2021: -7.1%FY 2022: -20.6%FY 2023: -34.4%FY 2024: -25.7%FY 2025: -5.5%
FY 2017 5y median -20.6% FY 2025
ROIC -12.3%
FY 2017: -31.9%FY 2018: -115.2%FY 2019: -5.3%FY 2020: -10.4%FY 2021: -5.8%FY 2022: -18.5%FY 2023: -31.2%FY 2024: -24.0%FY 2025: -12.3%
FY 2017 5y median -18.5% FY 2025
ROA -4.2%
FY 2017: -24.8%FY 2018: -90.5%FY 2019: -5.2%FY 2020: -58.4%FY 2021: -5.7%FY 2022: -16.1%FY 2023: -26.4%FY 2024: -19.9%FY 2025: -4.2%
FY 2017 5y median -16.1% FY 2025

Growth (YoY)

Revenue 5.2%
FY 2017: 0.0%FY 2018: 105.8%FY 2019: 68.1%FY 2020: 21.5%FY 2021: 64.1%FY 2022: 5.3%FY 2023: 19.8%FY 2024: -1.3%FY 2025: 5.2%
FY 2017 FY 2025
Operating Income 43.0%
FY 2017: 0.0%FY 2018: -502.8%FY 2019: 73.8%FY 2020: -193.5%FY 2021: 38.0%FY 2022: -217.4%FY 2023: -58.0%FY 2024: 26.7%FY 2025: 43.0%
FY 2017 FY 2025
EPS (diluted) 77.0%
FY 2017: 0.0%FY 2018: -418.5%FY 2019: 90.5%FY 2020: -571.3%FY 2021: 90.1%FY 2022: -175.5%FY 2023: -49.3%FY 2024: 30.3%FY 2025: 77.0%
FY 2017 FY 2025
Free Cash Flow 2371.2%
FY 2017: 0.0%FY 2018: -475.0%FY 2019: 90.2%FY 2020: -3048.6%FY 2021: 52.1%FY 2022: -34.7%FY 2023: 60.8%FY 2024: 91.1%FY 2025: 2371.2%
FY 2017 FY 2025

Financial Health

Current Ratio 4.5×
FY 2017: 3.1×FY 2018: 3.3×FY 2019: 7.6×FY 2020: 6.6×FY 2021: 6.8×FY 2022: 4.8×FY 2023: 4.7×FY 2024: 5.0×FY 2025: 4.5×
FY 2017 5y median 4.8× FY 2025
Quick Ratio 4.1×
FY 2017: 2.9×FY 2018: 3.0×FY 2019: 7.4×FY 2020: 6.3×FY 2021: 6.2×FY 2022: 4.2×FY 2023: 4.1×FY 2024: 4.3×FY 2025: 4.1×
FY 2017 5y median 4.2× FY 2025
Debt / Equity 0.2×
FY 2017: -0.1×FY 2018: -0.1×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.2×
FY 2017 5y median 0.1× FY 2025
Net Debt / EBITDA -80.9×
FY 2017: 2.7×FY 2018: 0.3×FY 2019: 18.9×FY 2020: 1.2×FY 2021: 20.6×FY 2022: 1.0×FY 2023: 1.3×FY 2024: 2.0×FY 2025: -80.9×
FY 2017 5y median 1.3× FY 2025
Interest Coverage 0.0×
FY 2017: -22.7×FY 2018: -46.0×FY 2019: -9.4×FY 2020: -50.7×FY 2021: -61.1×FY 2022: -353×FY 2023: -8040×FY 2024: -48640×FY 2025: 0.0×
FY 2017 5y median -353× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31